Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
about
Trazodone for the treatment of fibromyalgia: an open-label, 12-week studyTreatment of recurrent depressionPsychological therapies for treatment-resistant depression in adultsPharmacological interventions for treatment-resistant depression in adultsMirtazapine versus other antidepressive agents for depressionMajor depression symptoms in primary care and psychiatric care settings: a cross-sectional analysisVariation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatmentNeuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a reviewNoninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderA review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseRapid antidepressant effects: moving right alongA double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorderPsychomotor retardation in depression: biological underpinnings, measurement, and treatmentEvaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strainsTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersGenome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatientsThe molecular neurobiology of depressionA genomewide association study of citalopram response in major depressive disorderBupropion: a systematic review and meta-analysis of effectiveness as an antidepressantSystematic Review of the Neurobiological Relevance of Chemokines to Psychiatric DisordersChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsProfile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticePharmacological approaches to the challenge of treatment-resistant depressionGlia in the cytokine-mediated onset of depression: fine tuning the immune responseAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueEfficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysisKetamine, sleep, and depression: current status and new questionsNeurogenetics of depression: a focus on reward processing and stress sensitivityNeuromodulation for treatment-refractory major depressive disorderIdentifying serotonergic mechanisms underlying the corticolimbic response to threat in humansInnovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceCognitive mechanisms of treatment in depressionTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateKetamine for treatment-resistant unipolar depression: current evidencePharmacotherapy of postpartum depression: an updateCell atrophy and loss in depression: reversal by antidepressant treatmentA model for streamlining psychotherapy in the RDoC era: the example of 'Engage'
P2860
Q21257175-C2F24953-812B-4968-8E1B-7D9F2B192D12Q22305946-10A64CB6-374B-4E55-A835-B2E0BAB838CFQ24202603-1C73D284-2726-42A1-B3B4-254B02E77B4DQ24202611-5D167285-3E36-4DE9-9D37-23C4A4FD807DQ24234046-A7D01D12-B38B-4D0F-95CF-39960E04ECCBQ24288801-E071FD19-D1F4-43E5-97F6-770715B631B3Q24546379-5DC41807-13A0-4921-9BEF-779BCF758510Q24594131-0918C64C-8E99-4F9D-9E31-37F7B790B8C2Q24602982-DCA0A227-AF20-44B9-BDA5-C5C7152B2F78Q24602988-50F9632F-3BF0-4652-8760-2D0F0A7D9E44Q24606269-09514065-6216-47E4-8F0F-D63B3564F380Q24614410-D89BF59B-CDD4-4F1B-92A9-35A1A7812464Q24624059-D8CBA0EF-B400-46EF-A8C4-4005968D1140Q24629825-7B6C1460-F106-425C-8E9C-16D0DB2BED43Q24632901-50CEEE60-7714-4432-A265-1A573E7850FAQ24632936-87821870-8A3D-4528-A7A7-4E5041890956Q24650926-5D5CF962-26D8-448E-8E63-4C57546D60B9Q24656261-629722F5-57A3-45DC-A94B-8E7F6B39FBA9Q24656746-73A5052C-3AD2-49E2-8EB4-F2DEAC416398Q26747727-08DA14B1-A0B2-4685-B304-D68B855F2E81Q26781639-C8A84A75-AC73-43AD-9D97-EAC69CC193D3Q26782997-BCE7E2AC-3244-4AEC-8B61-1D07F84AD610Q26796436-2D1B95A0-391C-4623-8103-29CC0B39E13FQ26797416-C29DDF59-4F3A-4970-ABDA-64DEC346AD2CQ26798241-8AB6A448-230D-48A6-A668-E386BBEB797BQ26798929-E1D8F75A-49D7-49A4-8A50-1B1D6C64222EQ26827833-2B65CDED-F620-47DA-8BE1-ADCE396B95B7Q26828452-8981E422-7185-487B-9415-8115809710C1Q26828564-9B3DDC04-2881-4C98-B056-BF87311CEB48Q26830563-1CA25419-EDA2-402C-8A28-61CFA710261DQ26859023-3B2BE821-0103-479C-9D19-85904315E1DFQ26864503-C9A62467-1F8A-4AB1-8D86-82A8B680ADD3Q26996411-C884270D-0792-40E0-B82E-9487BD8903D8Q26999061-7569600C-5A7B-43AF-AC4A-FBEFAC699333Q27001088-DD12CD35-4345-4CE6-B8CE-854A277D5D26Q27004490-EFB28369-3B6F-42DF-90A0-3087877BCB6EQ27004508-CC95BD19-8BCD-4AFC-A0FB-8E958F57A1C8Q27010062-8CEEAD0F-4C29-4244-B065-9580E6A5CC92Q27013609-86C468F4-A187-4B53-A971-DC5CC7F96F08Q27022793-740DEFB2-0AD8-4204-A2A7-94BC17B8FDAE
P2860
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of outcomes with ci ...... ications for clinical practice
@ast
Evaluation of outcomes with ci ...... ications for clinical practice
@en
type
label
Evaluation of outcomes with ci ...... ications for clinical practice
@ast
Evaluation of outcomes with ci ...... ications for clinical practice
@en
prefLabel
Evaluation of outcomes with ci ...... ications for clinical practice
@ast
Evaluation of outcomes with ci ...... ications for clinical practice
@en
P2093
P3181
P1476
Evaluation of outcomes with ci ...... ications for clinical practice
@en
P2093
Balasubramani GK
Howland RH
Lebowitz B
McGrath PJ
Nierenberg AA
Norquist G
P3181
P356
10.1176/APPI.AJP.163.1.28
P407
P577
2006-01-01T00:00:00Z